{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:21:54Z","timestamp":1790749314588,"version":"4.1.0"},"reference-count":256,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ijid.2021.09.045","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T11:51:13Z","timestamp":1632397873000},"page":"300-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control"],"prefix":"10.1016","volume":"112","author":[{"given":"Philippe","family":"Buchy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Cintra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic E.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Ortiz de Lejarazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskild","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.09.045_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.552909","article-title":"Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses","volume":"11","author":"Abdelrahman","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.ijid.2021.09.045_bib0002","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1017\/dmp.2015.105","article-title":"Assessing the capacity of the US health care system to use additional mechanical ventilators during a large-scale public health emergency","volume":"9","author":"Ajao","year":"2015","journal-title":"Disaster Med Public Health Prep"},{"key":"10.1016\/j.ijid.2021.09.045_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.671833","article-title":"How can health systems better prepare for the next pandemic? lessons learned from the management of COVID-19 in Quebec (Canada)","author":"Alami","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2021.09.045_bib0004","doi-asserted-by":"crossref","first-page":"e00694","DOI":"10.1128\/AAC.00694-18","article-title":"Evaluation of MEDI8852, an anti-influenza A monoclonal antibody, in treating acute uncomplicated influenza","volume":"62","author":"Ali","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.09.045_bib0005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1086\/507154","article-title":"Is the 1918 influenza pandemic over? Long-term effects of in utero influenza exposure in the post-1940 US population","volume":"114","author":"Almond","year":"2006","journal-title":"J Polit Econ"},{"key":"10.1016\/j.ijid.2021.09.045_bib0006","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/pathogens9100829","article-title":"Genomic diversity and hotspot mutations in 30,983 SARS-CoV-2 genomes: moving toward a universal vaccine for the \u201cconfined virus\u201d?","volume":"9","author":"Alouane","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.ijid.2021.09.045_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhin.2018.05.021","article-title":"Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature","volume":"101","author":"Al-Tawfiq","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2021.09.045_bib0008","unstructured":"American Cancer Society. Why people with cancer are more likely to get infections. 2020. Available at: https:\/\/www.cancer.org\/treatment\/treatments-and-side-effects\/physical-side-effects\/low-blood-counts\/infections\/why-people-with-cancer-are-at-risk.html (accessed December 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0009","series-title":"Economics and the public welfare: a financial and economic history of the United States, 1914-1946","first-page":"61","author":"Anderson","year":"1979"},{"key":"10.1016\/j.ijid.2021.09.045_bib0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1080\/22221751.2020.1761267","article-title":"Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2","volume":"9","author":"Anderson","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijid.2021.09.045_bib0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/ni.3680","article-title":"Defining B cell immunodominance to viruses","volume":"18","author":"Angeletti","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0012","unstructured":"Anon. Janssen drops pimodivir development program in flu. 2020. Available at: https:\/\/www.thepharmaletter.com\/article\/janssen-drops-pimodivir-development-program-in-flu (accessed December 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0013","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1750-2659.2009.00080.x","article-title":"Mortality burden of the 1918\u20131919 influenza pandemic in Europe","volume":"3","author":"Ansart","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.ijid.2021.09.045_bib0014","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41591-021-01454-y","article-title":"COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries","volume":"27","author":"Arce","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0015","article-title":"Five coronavirus success stories: different, but the same","author":"Bacay Watson","year":"2020","journal-title":"Security Nexus, Daniel K Inouye Asia-Pacific Center for Security Studies"},{"key":"10.1016\/j.ijid.2021.09.045_bib0016","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy ans safety of the mRNA SARS-CoV2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0017","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/d41586-020-03626-1","article-title":"The lightning-fast quest for COVID vaccines \u2013 and what it means for other diseases","volume":"589","author":"Ball","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0018","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2020.11642","article-title":"Mortality, admissions, and patient census at SNFs in 3 US cities during the COVID-19 pandemic","volume":"324","author":"Barnett","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0019","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"Barouch","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.09.045_bib0020","article-title":"The coronavirus and the great influenza epidemic: lessons from the \u201cSpanish Flu\u201d for the coronavirus\u2019 potential effects on mortality and economic activity","author":"Barro","year":"2020","journal-title":"American Enterprise Institute"},{"key":"10.1016\/j.ijid.2021.09.045_bib0021","series-title":"The great influenza: the epic story of the deadliest plague in history","author":"Barry","year":"2005"},{"key":"10.1016\/j.ijid.2021.09.045_bib0022","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0141076820956802","article-title":"Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?","volume":"113","author":"Beaney","year":"2020","journal-title":"J Royal Soc Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0023","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-019-1717-y","article-title":"A new twenty-first century science for effective epidemic response","volume":"575","author":"Bedford","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0024","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2013 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0025","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1128\/JVI.02742-09","article-title":"Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice","volume":"84","author":"Belser","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0026","article-title":"Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19","author":"Bhimraj","year":"2021","journal-title":"Infectious Diseases Society of America"},{"key":"10.1016\/j.ijid.2021.09.045_bib0027","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0140-6736(13)61492-0","article-title":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk","volume":"382","author":"Breban","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0028","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(06)70466-2","article-title":"Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness","volume":"6","author":"Brundage","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0029","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0030","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0031","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijid.2019.10.005","article-title":"Impact of vaccines on antimicrobial resistance","volume":"90","author":"Buchy","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2021.09.045_bib0032","first-page":"82","article-title":"The U.S. military and the influenza pandemic of 1918\u20131919","volume":"125","author":"Byerly","year":"2010","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ijid.2021.09.045_bib0033","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1186\/s12889-021-11546-6","article-title":"Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"21","author":"Cai","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2021.09.045_bib0034","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S0140-6736(20)30418-9","article-title":"Statement in support of the scientists, public health professionals, and medical professionals of China in combatting COVID-19","volume":"395","author":"Callisher","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/d41586-020-01221-y","article-title":"The race for coronavirus vaccines: a graphical guide","volume":"580","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0036","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2666-5247(20)30002-1","article-title":"From PREDICT to prevention, one pandemic later","volume":"1","author":"Carlson","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2021.09.045_bib0037","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.aap7463","article-title":"The Global Virome Project","volume":"359","author":"Carroll","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.09.045_bib0038","doi-asserted-by":"crossref","first-page":"e00042","DOI":"10.1128\/mBio.00042-10","article-title":"Universal vaccines: shifting to one for many","volume":"1","author":"Cassone","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.ijid.2021.09.045_bib0039","unstructured":"Center for Infectious Disease Research and Policy (CIDRAP). Universal influenza vaccine technology landscape. 2020. Available at: https:\/\/www.cidrap.umn.edu\/universal-influenza-vaccine-technology-landscape (acessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0040","first-page":"1071","article-title":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) \u2013 United States, May\u2013August 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2021.09.045_bib0041","first-page":"363","article-title":"Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage \u2013 United States, October 2009\u2013January 2010","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2021.09.045_bib0042","unstructured":"Centers for Disease Control and Prevention. Past pandemics. 2018a. Available at: https:\/\/www.cdc.gov\/flu\/pandemic-resources\/basics\/past-pandemics.html (accessed December 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0043","unstructured":"Centers for Disease Control and Prevention. One Health Basics. 2018b. Available at: https:\/\/www.cdc.gov\/onehealth\/basics\/index.html (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0044","unstructured":"Centers for Disease Control and Prevention. Influenza historic timeline. 2019a. Available at: https:\/\/www.cdc.gov\/flu\/pandemic-resources\/pandemic-timeline-1930-and-beyond.htm (accessed December 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0045","unstructured":"Centers for Disease Control and Prevention. 1968 pandemic (H2N2 virus). 2019b. Available at: https:\/\/www.cdc.gov\/flu\/pandemic-resources\/1968-pandemic.html (accessed December 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0046","unstructured":"Centers for Disease Control and Prevention. Influenza antiviral drug resistance. 2020. Available at: https:\/\/www.cdc.gov\/flu\/treatment\/antiviralresistance.htm (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0047","unstructured":"Centers for Disease Control and Prevention. Influenza vaccination information for health care workers. 2021. Available at: https:\/\/www.cdc.gov\/flu\/professionals\/healthcareworkers.htm?CDC_AA_refVal=https%3A%2F%2Fwwwcdcgov%2Fflu%2Fhealthcareworkers.htm (accessed March 2021)."},{"issue":"4","key":"10.1016\/j.ijid.2021.09.045_bib0048","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00048-2021","article-title":"Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline","volume":"57","author":"Chalmers","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2021.09.045_bib0049","unstructured":"Chan M. World now at the start of 2009 influenza pandemic. 2009. Available at: https:\/\/www.who.int\/mediacentre\/news\/statements\/2009\/h1n1_pandemic_phase6_20090611\/en\/ (accessed September 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/cid\/cir644","article-title":"Mortality burden of the A\/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza","volume":"53","author":"Charu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0051","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(04)16255-7","article-title":"Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome","volume":"363","author":"Cheng","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0052","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2012.194139","article-title":"Bacterial coinfection in influenza: a grand rounds review","volume":"309","author":"Chertow","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000436","article-title":"Characterizing the epidemiology of the 2009 influenza A\/H1N1 pandemic in Mexico","volume":"8","author":"Chowell","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0054","unstructured":"CEPI (Coalition for Epidemic Preparedness Innovations). New vaccines for a safer world. 2020a. Available at: https:\/\/cepi.net (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0055","unstructured":"CEPI (Coalition for Epidemic Preparedness Innovations). How COVAX will work. 2020b. Available at: https:\/\/cepi.net\/COVAX\/ (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0056","first-page":"345","article-title":"Origin and progress of the 1968\u201369 Hong Kong influenza epidemic","volume":"41","author":"Cockburn","year":"1969","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2021.09.045_bib0057","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1473-3099(20)30426-6","article-title":"A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation","volume":"20","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0058","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.vaccine.2019.04.048","article-title":"Safety of AS03-adjuvanted influenza vaccines: a review of the evidence","volume":"37","author":"Cohet","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.09.045_bib0059","doi-asserted-by":"crossref","first-page":":115ra112","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virol.2006.09.029","article-title":"Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse","volume":"361","author":"Coughlin","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2021.09.045_bib0061","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12979-019-0164-9","article-title":"Immunosenescence and human vaccine immune responses","volume":"16","author":"Crooke","year":"2019","journal-title":"Immun Ageing"},{"key":"10.1016\/j.ijid.2021.09.045_bib0062","unstructured":"CS Mott Children's Hospital. Mott Poll Report. Flu vaccine for children in the time of COVID. 2020. Available at: https:\/\/mottpoll.org\/reports\/flu-vaccine-children-time-covid (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0063","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","article-title":"Emergence of a novel swine-origin influenza A (H1N1) virus in humans","volume":"360","author":"Dawood","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0064","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0065","doi-asserted-by":"crossref","first-page":"m1375","DOI":"10.1136\/bmj.m1375","article-title":"Covid-19: four fifths of cases are asymptomatic, China figures indicate","volume":"369","author":"Day","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2021.09.045_bib0066","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2021.09.045_bib0067","doi-asserted-by":"crossref","first-page":"e40385","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ijid.2021.09.045_bib0068","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.vaccine.2012.05.007","article-title":"Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010","volume":"30","author":"Domingues","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.09.045_bib0069","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development","volume":"87","author":"Du","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S1473-3099(20)30401-1","article-title":"When does a major outbreak become a public health emergency of international concern?","volume":"20","author":"Durrheim","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0071","unstructured":"European Federation of Pharmaceutical Industries and Associations (EFPIA). Health systems after COVID-19. A perspective on the future of European health systems. 2021. Available at: https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjQ-tPdj-3yAhUNHcAKHY0BCgQQFnoECCAQAQ&url=https%3A%2F%2Fwww.efpia.eu%2Fmedia%2F602847%2Fhealth-systems-after-covid-19_en.pdf&usg=AOvVaw374s2OdtBAx9zStoyh-ZSL (accessed September 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0072","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.75.23.11603-11613.2001","article-title":"Replication-defective vector based on a chimpanzee adenovirus","volume":"75","author":"Farina","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0073","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/jamainternmed.2020.2306","article-title":"Assessment of deaths from COVID-19 and from seasonal influenza","volume":"180","author":"Faust","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0074","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7326\/M20-3569","article-title":"Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults","volume":"173","author":"Fisher","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2016.09.001","article-title":"Molecular evolution of human coronavirus genomes","volume":"25","author":"Forni","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0076","first-page":"1","article-title":"Coronavirus conspiracy beliefs, mistrust, and compliance with government guidelines in England","author":"Freeman","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0077","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.3390\/ijerph17165893","article-title":"Key guidelines in developing a pre-emptive COVID-19 vaccination uptake promotion strategy","volume":"17","author":"French","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijid.2021.09.045_bib0078","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2213-8587(21)00089-9","article-title":"Associations between body-mass index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, cohort study","volume":"9","author":"Gao","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0079","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-020-2562-8","article-title":"Zoonotic host diversity increases in human-dominated ecosystems","volume":"584","author":"Gibb","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5858\/134.2.235","article-title":"Pulmonary pathologic findings of fatal 2009 pandemic influenza A\/H1N1 viral infections","volume":"134","author":"Gill","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0081","first-page":"63","article-title":"H1N1 vaccination","volume":"21","author":"Gilmour","year":"2010","journal-title":"Health Rep"},{"key":"10.1016\/j.ijid.2021.09.045_bib0082","unstructured":"GISAID. 2021. Available at: https:\/\/www.gisaid.org (accessed March 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0083","unstructured":"Global Virome Project. Preparing for the next pandemic. 2020. Available at: www.globalviromeproject.org (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0084","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.09.045_bib0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jinf.2020.05.073","article-title":"SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes","volume":"81","author":"Graham","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2021.09.045_bib0086","series-title":"The forgotten depression: 1921, the crash that cured itself","author":"Grant","year":"2014"},{"key":"10.1016\/j.ijid.2021.09.045_bib0087","doi-asserted-by":"crossref","unstructured":"Greaney A, Loes A, Crawford K, et\u00a0al. Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. bioRxiv: the preprint server for biology 2021. doi: 10.1101\/2020.12.31.425021.","DOI":"10.1101\/2020.12.31.425021"},{"key":"10.1016\/j.ijid.2021.09.045_bib0088","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-0036-1584797","article-title":"Update on human rhinovirus and coronavirus infections","volume":"37","author":"Greenberg","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0089","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.1978.03290210042022","article-title":"The Russian flu. Its history and implications for this year's influenza season","volume":"240","author":"Gregg","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0090","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2021.09.045_bib0091","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41564-018-0296-2","article-title":"Tracking virus outbreaks in the twenty-first century","volume":"4","author":"Grubaugh","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0092","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0093","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41562-020-01009-0","article-title":"Ranking the effectiveness of worldwide COVID-19 government interventions","volume":"4","author":"Haug","year":"2020","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.ijid.2021.09.045_bib0094","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1080\/21645515.2015.1082014","article-title":"Vaccination of healthcare workers: a review","volume":"11","author":"Haviari","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2021.09.045_bib0095","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0096","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and efficacy of NVX-CoV2373 Covid-19 vaccine","author":"Heath","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0097","doi-asserted-by":"crossref","first-page":"20248","DOI":"10.1073\/pnas.1320524110","article-title":"Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins","volume":"110","author":"Heaton","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0098","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/bsp.2009.0729","article-title":"Public health and medical responses to the 1957\u201358 influenza pandemic","volume":"7","author":"Henderson","year":"2009","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.ijid.2021.09.045_bib0099","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ebiom.2018.12.051","article-title":"Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: results from a randomized, double-blind, phase-2, placebo-controlled study","volume":"40","author":"Hershberger","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijid.2021.09.045_bib0100","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0140-6736(20)31201-0","article-title":"Revisiting the 1957 and 1968 influenza pandemics","volume":"395","author":"Honigsbaum","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0101","article-title":"Dexamethasone in hospitalized patients with Covid-19 \u2013 preliminary report","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12985-015-0422-1","article-title":"Bat origin of human coronaviruses","volume":"12","author":"Hu","year":"2015","journal-title":"Virol J"},{"key":"10.1016\/j.ijid.2021.09.045_bib0103","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1915341","article-title":"Baloxavir marboxil for prophylaxis against influenza in household contacts","volume":"383","author":"Ikematsu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0104","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.4269\/ajtmh.20-0812","article-title":"COVID-19-related infodemic and its impact on public health: a global social media analysis","volume":"103","author":"Islam","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijid.2021.09.045_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251605","article-title":"COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence","volume":"16","author":"Islam","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2021.09.045_bib0106","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0107","series-title":"Working paper 2004\u20132007","article-title":"The economic impact of an influenza pandemic","author":"James","year":"2006"},{"key":"10.1016\/j.ijid.2021.09.045_bib0108","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children","volume":"2014","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2021.09.045_bib0109","first-page":"165","article-title":"Influenza, 1957: a variant and the pandemic","volume":"1","author":"Jensen","year":"1958","journal-title":"Prog Med Virol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2021.09.045_bib0111","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/cid\/ciq008","article-title":"Epidemiology of 2009 pandemic influenza A (H1N1) in the United States","volume":"52","author":"Jhung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918\u20131920 \"Spanish\" influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0115","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0116","series-title":"Epidemic influenza: a survey","author":"Jordan","year":"1927"},{"key":"10.1016\/j.ijid.2021.09.045_bib0117","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2011.00076","article-title":"Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design","volume":"2","author":"Kaminski","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0118","doi-asserted-by":"crossref","first-page":"e69336","DOI":"10.7554\/eLife.69336","article-title":"Tracking excess mortality across countries during the COVID-119 pandemic with the World Mortality Dataset","volume":"10","author":"Karlinsky","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ijid.2021.09.045_bib0119","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048025","article-title":"Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys","volume":"11","author":"Kerr","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2021.09.045_bib0121","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1098\/rstb.1980.0004","article-title":"Influenza: viral determinants of the pathogenicity and epidemicity of an invariant disease of variable occurrence","volume":"288","author":"Kilbourne","year":"1980","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.ijid.2021.09.045_bib0122","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3201\/eid1201.051254","article-title":"Influenza pandemics of the 20th century","volume":"12","author":"Kilbourne","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0123","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.1038\/s41598-018-28706-1","article-title":"The influenza virus hemagglutinin head evolves faster than the stalk domain","volume":"8","author":"Kirkpatrick","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2021.09.045_bib0124","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0125","article-title":"New coronavirus variants could cause more reinfections, require updated vaccines","author":"Kupferschmidt","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.09.045_bib0126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(20)32228-5","article-title":"Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage","volume":"397","author":"Lal","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0127","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2021.09.045_bib0128","article-title":"Genetic variants of SARS-CoV-2 \u2013 what do they mean?","author":"Lauring","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0129","first-page":"eabe6522","article-title":"Immunological characteristics govern the transition of COVID-19 to endemicity","author":"Lavine","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.09.045_bib0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0131","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/cid\/ciaa418","article-title":"Asymptomatic and presymptomatic infectors: hidden sources of COVID-19 disease","volume":"71","author":"Li","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0132","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.09.045_bib0133","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/aje\/kwh273","article-title":"Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore","volume":"160","author":"Li","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0134","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0135","doi-asserted-by":"crossref","unstructured":"Linka K, Peirlinck M, Kuhl E. The reproduction number of COVID-19 and its correlation with public health interventions. medRxiv: the preprint server for health sciences 2020. doi: 10.1101\/2020.05.01.20088047.","DOI":"10.1101\/2020.05.01.20088047"},{"key":"10.1016\/j.ijid.2021.09.045_bib0136","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1126\/science.1086616","article-title":"Transmission dynamics and control of severe acute respiratory syndrome","volume":"300","author":"Lipsitch","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.09.045_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0138","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJMoa0910444","article-title":"Severe 2009 H1N1 influenza in pregnant and postpartum women in California","volume":"362","author":"Louie","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0139","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0140","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMp2005630","article-title":"Developing Covid-19 vaccines at pandemic speed","volume":"382","author":"Lurie","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0141","series-title":"Disease control priorities: improving health and reducing poverty","article-title":"Pandemics: risks, impacts, and mitigation","author":"Madhav","year":"2017"},{"key":"10.1016\/j.ijid.2021.09.045_bib0142","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0143","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-020-03217-0","article-title":"Coronaviruses closely related to the pandemic virus discovered in Japan and Cambodia","volume":"588","author":"Mallapaty","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0144","first-page":"177","article-title":"Influenza-associated mortality during the 1918\u20131919 influenza pandemic in Alaska and Labrador","volume":"37","author":"Mamelund","year":"2013","journal-title":"Soc Sci Hist"},{"key":"10.1016\/j.ijid.2021.09.045_bib0145","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.298.6.644","article-title":"Nonpharmaceutical interventions implemented by US cities during the 1918\u20131919 influenza pandemic","volume":"298","author":"Markel","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0146","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2017.15033","article-title":"The critical role of biomedical research in pandemic preparedness","volume":"318","author":"Marston","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0147","first-page":"1","article-title":"Videos, views, and vaccines: evaluating the quality of COVID-19 communications on YouTube","author":"Marwah","year":"2021","journal-title":"Disaster Med Public Health Prep"},{"key":"10.1016\/j.ijid.2021.09.045_bib0148","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cid\/ciaa433","article-title":"The VACCINES Act: deciphering vaccine hesitancy in the time of COVID-19","volume":"71","author":"McAteer","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0149","doi-asserted-by":"crossref","first-page":"e01154","DOI":"10.1128\/AAC.01154-17","article-title":"Phase 2 randomized trial of the safety and efficacy of MHAA4549A, a broadly neutralizing monoclonal antibody, in a human influenza A virus challenge model","volume":"61","author":"McBride","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.09.045_bib0150","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept step study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0151","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijid.2020.09.1464","article-title":"A systematic review and meta-analysis of published research data on COVID-19 infection-fatality rates","volume":"101","author":"Meyerowitz-Katz","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0152","unstructured":"Milken Institute. COVID-19 treatment and vaccine tracker. 2021. Available at: https:\/\/covid-19tracker.milkeninstitute.org\/ (accessed March 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0153","article-title":"Americans immersed in COVID-19 news; most think media are doing fairly well covering it","author":"Mitchell","year":"2020","journal-title":"Pew Research Center"},{"key":"10.1016\/j.ijid.2021.09.045_bib0154","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0155","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/CCM.0b013e3181ceb25b","article-title":"The 1918 influenza pandemic: lessons for 2009 and the future","volume":"38","author":"Morens","year":"2010","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ijid.2021.09.045_bib0156","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/ijd.IJD_379_17","article-title":"Emerging infectious diseases: epidemiological perspective","volume":"62","author":"Mukherjee","year":"2017","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0157","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0158","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/S0140-6736(06)69895-4","article-title":"Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918\u201320 pandemic: a quantitative analysis","volume":"368","author":"Murray","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0159","unstructured":"National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. 2021. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/ (accessed 31 August). Accessed September 2021."},{"key":"10.1016\/j.ijid.2021.09.045_bib0160","series-title":"Exploring lessons learned from a century of outbreaks: readiness for 2030: proceedings of a workshop","author":"Nicholson","year":"2019"},{"key":"10.1016\/j.ijid.2021.09.045_bib0161","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijid.2020.02.060","article-title":"Serial interval of novel coronavirus (COVID-19) infections","volume":"93","author":"Nishiura","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0162","unstructured":"Ofcom. Half of UK adults exposed to false claims about coronavirus. 2020. Available at: https:\/\/www.ofcom.org.uk\/about-ofcom\/latest\/features-and-news\/half-of-uk-adults-exposed-to-false-claims-about-coronavirus (accessed September 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0163","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coviro.2020.02.003","article-title":"Tracking progress in universal influenza vaccine development","volume":"40","author":"Ostrowsky","year":"2020","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0164","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/d41586-021-01762-w","article-title":"COVID vaccines to reach poorest countries in 2023 - despite recent pledges","volume":"595","author":"Padma","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-020-00300-x","article-title":"Vaccines for SARS-CoV-2: lessons from other coronavirus strains","volume":"9","author":"Padron-Regalado","year":"2020","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijid.2021.09.045_bib0166","doi-asserted-by":"crossref","first-page":"e00150","DOI":"10.1128\/mBio.00150-11","article-title":"Why do influenza virus subtypes die out? A hypothesis","volume":"2","author":"Palese","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.ijid.2021.09.045_bib0167","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for COVID-19 - interim WHO SOLIDARITY trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0168","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jval.2016.05.005","article-title":"Value for money in H1N1 influenza: a systematic review of the cost-effectiveness of pandemic interventions","volume":"20","author":"Pasquini-Descomps","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.ijid.2021.09.045_bib0169","series-title":"Pandemic influenza, 1700\u20131900: a study in historical epidemiology","author":"Patterson","year":"1986"},{"key":"10.1016\/j.ijid.2021.09.045_bib0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyaa033","article-title":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","volume":"49","author":"Peeri","year":"2020","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0171","doi-asserted-by":"crossref","unstructured":"Peng Y, Mentzer AJ, Liu G, et\u00a0al. Broad and strong memory CD4 (+) and CD8 (+) T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients. 2020. bioRxiv 2020 8;2020.06.05.134551. doi: 10.1101\/2020.06.05.134551.","DOI":"10.1101\/2020.06.05.134551"},{"key":"10.1016\/j.ijid.2021.09.045_bib0172","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cmi.2017.10.035","article-title":"Emerging infections - an increasingly important topic: review by the Emerging Infections Task Force","volume":"24","author":"Petersen","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2021.09.045_bib0173","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0174","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0175","article-title":"Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review","volume":"7","author":"Piechotta","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2021.09.045_bib0176","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0177","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fmed.2019.00109","article-title":"Drugs for influenza treatment: is there significant news?","volume":"6","author":"Principi","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0178","unstructured":"Public Health England. Excess weight and COVID-19: insights from new evidence. 2020. Available at: https:\/\/www.gov.uk\/government\/publications\/excess-weight-and-covid-19-insights-from-new-evidence (accessed September 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0179","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2018.00123","article-title":"Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture","volume":"9","author":"Raj\u00e3o","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijid.2021.09.045_bib0181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109986","article-title":"Prioritizing zoonoses: a proposed one health tool for collaborative decision-making","volume":"9","author":"Rist","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijid.2021.09.045_bib0182","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-020-1000-7","article-title":"Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling","volume":"26","author":"Rockett","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0184","unstructured":"Rogers K. Hong Kong flu of 1968. 2020. Available at: http:\/\/www.britannica.com\/event\/Hong-Kong-flu-of-1968 (accessed 25 September 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2020.113356","article-title":"Conspiracy theories as barriers to controlling the spread of COVID-19 in the US","volume":"263","author":"Romer","year":"2020","journal-title":"Soc Sci med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0186","doi-asserted-by":"crossref","first-page":"e25215","DOI":"10.2196\/25215","article-title":"Patterns of media use, strength of belief in COVID-19 conspiracy theories, and the prevention of COVID-19 From March to July 2020 in the United States: survey study","volume":"23","author":"Romer","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.ijid.2021.09.045_bib0187","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2018.08.005","article-title":"Aging and the immune system: an overview","volume":"463","author":"Sadighi Akha","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ijid.2021.09.045_bib0188","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1-2a trial of Ad26.COV2.S Covid-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0189","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26CoV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/vaccines9020160","article-title":"COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates","volume":"9","author":"Sallam","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"Suppl 4","key":"10.1016\/j.ijid.2021.09.045_bib0191","doi-asserted-by":"crossref","first-page":"D66","DOI":"10.1016\/j.vaccine.2015.09.035","article-title":"Vaccine hesitancy: causes, consequences, and a call to action","volume":"33","author":"Salmon","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2021.09.045_bib0192","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.3201\/eid2313.170418","article-title":"Prioritizing zoonoses for global health capacity building \u2013 themes from one health zoonotic disease workshops in 7 countries, 2014\u20132016","volume":"23","author":"Salyer","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0193","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5965836","article-title":"An Overview of the 2009 A(H1N1) pandemic in Europe: efficiency of the vaccination and healthcare strategies","volume":"2016","author":"Samanlioglu","year":"2016","journal-title":"J Healthc Eng"},{"key":"10.1016\/j.ijid.2021.09.045_bib0194","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.17359","article-title":"Exploring the gap between excess mortality and COVID-19 deaths in 67 countries","volume":"4","author":"Sanmarchi","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.ijid.2021.09.045_bib0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/pathogens5040066","article-title":"Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission","volume":"5","author":"Saunders-Hastings","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.ijid.2021.09.045_bib0196","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines6020029","article-title":"Clinical advances in viral-vectored influenza vaccines","volume":"6","author":"Sebastian","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2021.09.045_bib0197","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20072681","article-title":"The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?","volume":"205","author":"Sekaly","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0198","unstructured":"Settele J, Diaz S, Brondizio E, et\u00a0al. COVID-19 stimulus measures must save lives, protect livelihoods, and safeguard nature to reduce the risk of future pandemics. IBPES Expert Guest Article, 2020. Available at: https:\/\/ipbes.net\/covid19stimulus (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0199","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S1473-3099(18)30178-6","article-title":"The unusually diverse mortality patterns in the Pacific region during the 1918\u201321 influenza pandemic: reflections at the pandemic's centenary","volume":"18","author":"Shanks","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0200","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(10)60421-7","article-title":"Experts concerned about vaccination backlash","volume":"375","author":"Shetty","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0201","doi-asserted-by":"crossref","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: Global initiative on sharing all influenza data \u2013 from vision to reality","volume":"22","author":"Shu","year":"2017","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2021.09.045_bib0202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001558","article-title":"Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study","volume":"10","author":"Simonsen","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0203","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy088","article-title":"Using clinical research networks to assess severity of an emerging influenza pandemic","volume":"67","author":"Simonsen","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(00)78541-2","article-title":"A virus obtained from influenza patients","volume":"222","author":"Smith","year":"1933","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0205","article-title":"Building a better health care system post-COVID-19: steps for reducing low-value and wasteful care","author":"Sorensen","year":"2020","journal-title":"NEJM Catalyst"},{"key":"10.1016\/j.ijid.2021.09.045_bib0206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pervac.2011.05.003","article-title":"Vaccine antigens","volume":"1","author":"Strugnell","year":"2011","journal-title":"Perspectives in vaccinology"},{"key":"10.1016\/j.ijid.2021.09.045_bib0207","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0208","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008536","article-title":"The hallmarks of COVID-19 disease","volume":"16","author":"Tang","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2021.09.045_bib0209","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0211","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0212","unstructured":"Tegally H, Wilkinson E, Giovanetti M, et\u00a0al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. 2021. Available at: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.12.21.20248640v1 (accessed February 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0213","article-title":"COVID-19: time to flatten the infodemic curve","volume":"1\u20135","author":"Tentolouris","year":"2021","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0214","unstructured":"The Economist. Tracking covid-19 excess deaths across countries. 2021. Available at: https:\/\/www.economist.com\/graphic-detail\/coronavirus-excess-deaths-tracker (accessed September 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0215","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2021.09.045_bib0217","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/shm\/5.3.435","article-title":"The failure of expertise: public health policy in Britain during the 1918\u201319 influenza epidemic","volume":"5","author":"Tomkins","year":"1992","journal-title":"Soc Hist Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0218","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3201\/eid1012.040520","article-title":"Antibodies to SARS coronavirus in civets","volume":"10","author":"Tu","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0219","unstructured":"USAID PREDICT. Reducing pandemic risk, promoting global health. 2020. Available at: https:\/\/www.usaid.gov\/sites\/default\/files\/documents\/1864\/predict-global-flyer-508.pdf (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0220","first-page":"1","article-title":"Why do people believe COVID-19 conspiracy theories?","volume":"1","author":"Uscinski","year":"2020","journal-title":"Harvard Kennedy School (HKS) Misinform Rev"},{"key":"10.1016\/j.ijid.2021.09.045_bib0221","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0222","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2021.09.045_bib0223","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1465-7295.1991.tb00847.x","article-title":"The 1920-21 Deflation: the role of aggregate supply","volume":"29","author":"Vernon","year":"1991","journal-title":"Economic Inquiry"},{"key":"10.1016\/j.ijid.2021.09.045_bib0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/431150","article-title":"Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic","volume":"192","author":"Viboud","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0226","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/infdis\/jiv534","article-title":"Global mortality impact of the 1957\u20131959 influenza pandemic","volume":"213","author":"Viboud","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0228","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2021.09.045_bib0229","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000330673","article-title":"Chronic kidney disease and risk of death from infection","volume":"34","author":"Wang","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0230","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/vaccines8030482","article-title":"Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2021.09.045_bib0231","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2021.09.045_bib0232","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2021.09.045_bib0233","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","article-title":"Can we contain the COVID-19 outbreak with the same measures as for SARS?","volume":"20","author":"Wilder-Smith","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0234","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038489","article-title":"The ecology and evolution of influenza viruses","volume":"10","author":"Wille","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijid.2021.09.045_bib0235","doi-asserted-by":"crossref","first-page":"n623","DOI":"10.1136\/bmj.n623","article-title":"Covid-19: highest death rate seen in countries with most overweight populations","volume":"372","author":"Wise","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2021.09.045_bib0236","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2021.09.045_bib0224","doi-asserted-by":"crossref","unstructured":"Hul V, Karlsson EA, Hassanin A, et\u00a0al. A novel SARS-CoV-2 related coronavirus in bats from Cambodia. 2021. bioRxiv preprint doi: https:\/\/doi.org\/10.1101\/2021.01.26.428212","DOI":"10.1101\/2021.01.26.428212"},{"key":"10.1016\/j.ijid.2021.09.045_bib0237","unstructured":"World Health Organization. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). 2003. Available at: https:\/\/www.who.int\/csr\/sars\/WHOconsensus.pdf?ua=1 (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0239","unstructured":"World Health Organization. Strengthening response to pandemics and other public-health emergencies: report of the review committee on the functioning of the international health regulations (2005) and on Pandemic Influenza (H1N1) 2009. 2011. https:\/\/www.who.int\/ihr\/publications\/RC_report\/en\/ (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0240","unstructured":"World Health Organization. Report of the WHO pandemic influenza A(H1N1) vaccine deployment initiative. 2012. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/44795 (accessed March 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0241","unstructured":"World Health Organization. About IHR. 2016. Available at: https:\/\/www.who.int\/ihr\/about\/en\/ (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0242","unstructured":"World Health Organization. Draft thirteenth general programme of work, 2019\u20132023. 2018. Available at: http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA71\/A71_4-en.pdf?ua=1 (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0243","unstructured":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). MERS monthly summary, November 2019. Available at: https:\/\/www.who.int\/emergencies\/mers-cov\/en\/ (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0244","unstructured":"World Health Organization. Pandemic influenza. 2020a. Available at: https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/pandemic-influenza (accessed December 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0245","unstructured":"World Health Organization. Influenza. Global Influenza Surveillance and Response System (GISRS). 2020b. Available at: https:\/\/www.who.int\/influenza\/gisrs_laboratory\/en\/ (accessed January 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0246","unstructured":"World Health Organization. Influenza. Surveillance and monitoring. 2020c. Available at: https:\/\/www.who.int\/influenza\/surveillance_monitoring\/en\/ (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0247","unstructured":"World Health Organization. Pandemic influenza preparedness (PIP) framework. 2020d. Available at: https:\/\/www.who.int\/influenza\/pip\/en\/ (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0248","unstructured":"World Health Organization. Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness. 2020e. Available at: https:\/\/www.who.int\/influenza\/vaccines\/virus\/202009_zoonotic_vaccinevirusupdate.pdf?ua=1 (accessed October 2020)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0249","unstructured":"World Health Organization. Influenza. COVID-19 sentinel surveillance by GISRS. 2021a. Available at: https:\/\/www.who.int\/influenza\/gisrs_laboratory\/covid19\/en\/ (accessed January 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0250","unstructured":"World Health Organization. Therapeutics and COVID-19 Living Guideline (6 July 2021). 2021b. Available at: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-therapeutics-2021.2 (accessed September 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0251","unstructured":"World Health Organization. Coronavirus disease (COVID-19) advice for the public: mythbusters. 2021c. Available at: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public\/myth-busters#virus (accessed September 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0252","unstructured":"World Health Organization. Draft landscape of COVID-19 candidate vaccines. 2021d. Available at: https:\/\/www.who.int\/who-documents-detail\/draft-landscape-of-covid-19-candidate-vaccines2020 (accessed February 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0253","unstructured":"World Obesity Federation. Obesity and COVID-19: policy statement. 2012. Available at: https:\/\/www.worldobesity.org\/news\/obesity-and-covid-19-policy-statement (accessed September 2021)."},{"key":"10.1016\/j.ijid.2021.09.045_bib0254","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3201\/eid1603.091216","article-title":"School closure and mitigation of pandemic (H1N1) 2009, Hong Kong","volume":"16","author":"Wu","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0256","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s13054-020-03189-7","article-title":"Efficacy of convalescent plasma for the treatment of severe influenza","volume":"24","author":"Xu","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijid.2021.09.045_bib0257","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08989621.2020.1782203","article-title":"An alrming retraction rate for scientific publications on coronavirus disease 2019 (COVID-19)","volume":"28","author":"Yeo-Teh","year":"2021","journal-title":"Account Res"},{"key":"10.1016\/j.ijid.2021.09.045_bib0258","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.045_bib0259","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ijid.2021.09.045_bib0260","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:35Z","timestamp":1761120275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221007529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":256,"alternative-id":["S1201971221007529"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.045","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 pandemic: lessons learned from more than a century of pandemics and current vaccine development for pandemic control","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}